NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-214-2021-2-IL-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides IL National Stage 305174 Pending
NIAID E-055-2021-0-KR-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use KR National Stage 10-2023-7027608 Pending
NIAID E-140-2022-0-PC-01 Dual-Germline Antibody Engager HIV-1 Envelope Chimeric Immunogens PCT PCT PCT/US2023/072123 Expired
NCI E-158-2023-0-US-01 POLYFLUORINATED THALIDOMIDE ANALOGS AND USES THEREOF US 63/518,823 Expired
NCI E-169-2024-0-US-01 LNA Gapmers Inhibit Growth of Pancreatic Cancer US 63/531,993 Expired
NIAID E-214-2021-2-MX-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides MX National Stage MX/A/2023/009417 Pending
NCI E-029-2021-0-CA-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 CA National Stage 3207989 Pending
NIAID E-214-2021-2-CA-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides CA National Stage 3207998 Pending
NIAID E-191-2023-0-US-02 METHODS OF MODELING IN VIVO EFFICACY OF DRUG COMBINATIONS FOR TREATMENT OF VIRAL INFECTIONS US National Stage 18/276,599 Pending
NCATS E-046-2021-0-CN-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CN National Stage 202180093259.3 Pending
NCI E-256-2020-0-EP-01 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS 		EP National Stage 22705222.2 Pending
NCI E-243-2020-0-EP-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER EP National Stage 22705630.6 Pending
NIAID E-037-2021-1-JP-10 Antibodies Targeting The Spike Protein Of Coronaviruses JP National Stage 2023-547766 Pending
NIA E-151-2022-0-PC-01 HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE PCT PCT PCT/US2023/029602 Expired
NIDDK E-051-2021-0-EP-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS EP National Stage 22701105.3 Abandoned
NIAID E-052-2017-4-MY-01 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection MY DIV PI 2023004262 Abandoned
NIAID E-037-2021-1-MX-12 Antibodies Targeting The Spike Protein Of Coronaviruses MX National Stage MX/a/2023/009244 Pending
NCI E-064-2021-0-US-02 Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection US National Stage 18/275,925 Pending
NEI E-094-2016-0-JP-01 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY JP DIV 2023-127909 Pending
NEI E-094-2016-0-JP-02 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY JP DIV 2023-127908 Pending
NCATS E-232-2017-0-JP-01 Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders JP DIV 2023-127334 Issued
NIAID E-037-2021-1-IL-08 Antibodies Targeting The Spike Protein Of Coronaviruses IL National Stage 304955 Pending
NIAID E-038-2017-1-US-05 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US CON 18/364,104 Abandoned
NIAID E-037-2021-1-US-01 Antibodies Targeting The Spike Protein Of Coronaviruses US National Stage 18/263,995 Pending
NIAID E-002-2023-1-US-01 VESICULAR STOMATITIS VIRUS (VSV)-BASED VACCINE AGAINST SUDAN VIRUS US 63/517,246 Expired
NCI E-088-2023-0-US-01 DEVELOPMENT OF NOVEL ANTIBODIES AND SINGLE CHAIN VARIABLE FRAGMENTS AGAINST EXTRACELLULAR PRAME US 63/530,440 Expired
NCATS E-204-2022-2-PC-01 MULTI-CYCLIC IRAK1 AND IRAK4 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2023/071435 Expired
NCATS E-204-2022-3-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/516,771 Expired
NIBIB E-157-2023-0-US-01 Rapid spectral unmixing using Spectrally Interpolated Background Reduction (SIBR) US 63/529,866 Expired
NIAID E-037-2021-1-BR-03 Antibodies Targeting The Spike Protein Of Coronaviruses BR National Stage BR112023015424-3 Pending
NCI E-237-2017-2-JP-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 JP DIV 2023-123893 Issued
NIAID E-177-2022-0-PCT-02 Monoclonal Antibodies that bind to the underside of Influenza Viral Neuraminidase PCT PCT PCT/US2023/071194 Expired
NCI E-243-2020-0-US-02 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER US National Stage 18/263,394 Pending
NCI E-243-2020-0-JP-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER JP National Stage 2023-545802 Pending
NCI E-243-2020-0-CA-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER CA National Stage 3210086 Pending
NIDA E-133-2022-0-PCT-01 SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS PCT PCT PCT/US2023/071022 Expired
NHLBI E-056-2021-0-US-02 A New Molecular Scaffold For Targeting HRpn13 US National Stage 18/262,941 Pending
NCI E-016-2018-0-US-02 CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS US DIV 18/359,071 Pending
NEI E-033-2021-0-EP-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF EP National Stage 21742557.8 Pending
NIAID E-154-2022-0-PC-01 METHOD OF IMMMUNOFOCUSING AN IMMUNE RESPONSE PCT PCT PCT/US2023/070926 Expired
NEI E-293-2016-0-US-02 TISSUE CLAMP AND IMPLANTATION METHOD US DIV 18/226,043 Pending
NCI E-036-2018-0-US-03 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS US CON 18/358,068 Pending
NCI E-256-2020-0-US-04 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS 		US National Stage 18/262,779 Pending
NHLBI E-056-2021-0-IL-01 A New Molecular Scaffold For Targeting HRpn13 IL National Stage 304725 Abandoned
NIAID E-037-2021-1-CA-04 Antibodies Targeting The Spike Protein Of Coronaviruses CA National Stage 3209136 Pending
NEI E-033-2021-0-AU-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF AU National Stage 2021417166 Pending
NIDDK E-051-2021-0-AU-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS AU National Stage 2022207045 Pending
NCATS E-119-2023-0-US-01 HYPOTHALAMIC DIFFERENTIATION FROM PLURIPOTENT STEM CELLS US 63/528,273 Expired
NIAID E-165-2023-0-US-01 Bispecific antibodies that broadly target coronaviruses US 63/528,158 Expired
NIBIB E-179-2023-0-US-01 A SINGLE-MOLECULE MICROSCOPY METHOD TO MEASURE DRUG-INDUCED DNA TRAPPING OF CELLULAR TOPOISOMERASES AND POLYADP-RIBOSE POLYMERASES IN REAL-TIME US 63/528,291 Abandoned